Vivo Capital »

Pharvaris N V shares owned by Vivo Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Vivo Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.0M 285k 28.05

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Geron Corp Common (GERN)
Harmony Biosciences Holdings Common (HRMY)
Sinovac Biotech SHS (SVA)
Avadel Pharmaceuticals Adr (AVDL)
Verona Pharma Sponsored Ads (VRNA)
ALX Oncology Holdings Common (ALXO)
Dyne Therapeutics Common (DYN)
Terns Pharmaceuticals Common (TERN)
Astria Therapeutics Common (ATXS)
Viridian Therapeutics Common (VRDN)
Silence Therapeutics Ads (SLN)
Olema Pharmaceuticals Common (OLMA)
Adverum Biotechnologies Common
Alpine Immune Sciences Common (ALPN)

View all positions for Vivo Capital

Top funds holding Pharvaris N V

venBio Partners
Viking Global Investors
VR Adviser
Cormorant Asset Management
EcoR1 Capital
T. Rowe Price Associates
Deerfield Management Company
Commodore Capital
5AM Venture Management
Sphera Funds Management
Soleus Capital Management
Millennium Management
Citadel Advisors
Blackstone Group
Walleye Trading Advisors

View all funds holding Pharvaris N V